How often does Amgen say “Patent” 2+ times on earnings calls?
Amgen said Patent2+× in 1 of the last 5 calls. 5 uses in all, up to 3 in one call. Most recently on Thu Apr 30.
Record over the last 5 calls by Amgen
Oldest to newest · Nov 4, 2025 – Nov 3, 2026
- Said 2 or more times in
- 1 of 5
- Uses
- 5
- Per call
- 1.0
- Last said
- Apr 30
5 calls counted36 on file
Appearances counted
5 callsOur count of the transcript. Kalshi settles.
| Date | Appearance | Uses | |
|---|---|---|---|
| Q3 2026 earnings call | 0 | none | |
| Q2 2026 earnings callpatent 1 · needs 2 | 1 | patent 1 · needs 2 | |
| Q1 2026 earnings callpatent 3 | 3 | patent 3 | |
| Q4 2025 earnings call | 0 | none | |
| Q3 2025 earnings callpatents 1 · needs 2 | 1 | patents 1 · needs 2 | |
| 10 earlier calls, Apr 2023 – Aug 2025, in Pro | |||
Loading boards
More words Kalshi has listed for Amgen
Said in how many of the last 5 calls by Amgen
- VESALIUS-CVsaid in 5 of 5
- GLP-1 / GLPsaid in 5 of 5
- Eosinophilicsaid in 4 of 5
- Dazodalibepsaid in 3 of 5
- Tavneossaid in 3 of 5
- Oral3+×said in 2 of 5
- ESMOsaid in 2 of 5
- Medicaresaid in 2 of 5
- Acquisitionsaid in 2 of 5
- Artificial Intelligence3+×said in 1 of 5
- Imfinzi / Durvalumabsaid in 1 of 5
- Prolia2+×said in 1 of 5
Market words from Kalshi · Powered by Kalshi Research (opens in a new tab) · Each count is ours, by the market’s rules: How we count → · A count looks wrong? Report it (email)